Article
Transglutaminase 2 exacerbates ovarian cancer survival by inactivating GSK3β
2025-08-13
Abstract excerpt
<title>Abstract</title> <p>Elevated expression of transglutaminase 2 (TGase 2, EC 2.3.2.13, protein-glutamine g-glutamyltransferase, gene name TGM2) is recognized as one of the most upregulated genes during epithelial-mesenchymal transition (EMT) in ovarian cancer. Despite initial complete responses to conventional chemotherapy, ovarian cancer often recurs with metastasis, posing a major clinical challenge. Drug-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 032f839b-7c70-5865-a163-16591cafc19e
- DOI
- 10.21203/rs.3.rs-7297143/v1
